Previously submitted to: Interactive Journal of Medical Research (no longer under consideration since Apr 08, 2024)
Date Submitted: Mar 31, 2023
Open Peer Review Period: Mar 31, 2023 - Apr 17, 2023
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Use of IQOSTM (A Heated Tobacco Product) in Italy: Results from Two Cross-sectional Studies
ABSTRACT
Background:
Heated tobacco products (HTPs) such as IQOSTM are alternatives to cigarettes that heat rather than burn tobacco. Few data are available on the use of these products in Italy.
Objective:
To characterize how Italian adults use tobacco- and nicotine-containing products (TNPs), including smoke-free products such as IQOS, we surveyed Italian adults (users of legal age) about their current and past use of using smoke-free TNPs in from 2018 to 2020.
Methods:
We analyzed data from two consecutive cross-sectional surveys conducted in representative samples of the general adult population (6,095 subjects from 2018 to 2019 and 6,118 from 2019 to 2020) and IQOS users (1,371 subjects from 2018 to 2019 and 1,401 from 2019 to 2020) in Italy. We assessed the prevalence of current TNP use in the general population sample and the patterns of use in the IQOS users sample.
Results:
In the first cross-sectional study (2018-2019), cigarettes were the most used TNP (24.3%). Only small proportions used e-cigarettes or IQOS (1.4% and 0.7%, respectively). Nearly all current IQOS users were current adult cigarette smokers when they started using IQOS (98.0%). Some respondents used both IQOS and combustible TNPs (38.6%); however, most IQOS users (59.2%) exclusively used IQOS. Exclusive IQOS users reported improved respiratory symptoms (cough and phlegm) and exercise capacity compared to a year before they started using IQOS. Most current IQOS users also reported improved smell and taste, better smelling breath, and reduced teeth staining. Overall, these results were more pronounced among exclusive IQOS users. The results of the second cross-sectional study (2019-2020) were similar, except for a slight increase in IQOS use (1.1% vs. 0.7% from 2018 to 2019).
Conclusions:
These studies show that most TNP users smoke cigarettes in Italy. The uptake of IQOS shows that it is a viable alternative to cigarettes; nearly all IQOS users switched from cigarettes to IQOS. Furthermore, most IQOS users exclusively use the product. Notably, respondents reported improved health, hygiene, and appearance after switching from cigarettes to IQOS.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.